GENESEGUES THERAPEUTICS
Similar Organizations
ImCure Therapeutics
ImCure Therapeutics
Inex Pharmaceuticals
Inex Pharmaceuticals
Traxion Therapeutics Inc
Traxion Therapeutics Inc
More informations about "GeneSegues Therapeutics"
Cancer Treatment Startup Based on U Research Wins …
Nov 18, 2016 GeneSegues Therapeutics received the Minnesota High Tech Association’s Tekne Award Wednesday night in the category of Health Care — Small and Growing. Tekne Awards recognize innovation across Minnesota in …See details»
GeneSegues Therapeutics - Crunchbase Company Profile & Funding
Who are GeneSegues Therapeutics's competitors? Alternatives and possible competitors to GeneSegues Therapeutics may include Diorasis Therapeutics, Genex Space, and ImCure …See details»
GENESEGUES INC | SBIR.gov
The design, fabrication, characterization, and preclinical evaluation of novel nanoparticle-based drug formulations capable of delivering candidate RNAi therapeutics for the treatment of cancer.See details»
GeneSegues Therapeutics - Crunchbase
GeneSegues Therapeutics, Diorasis Therapeutics, ImCure Therapeutics, and Traxion Therapeutics Inc are all involved in the biotechnology and pharmaceutical industry.See details»
Geneos Therapeutics - Exquisitely Personalized Immunotherapies
Apr 7, 2024 Geneos Therapeutics, a Phase 2 biotherapeutics company, is developing DNA-based personalized therapeutic cancer vaccines (PTCVs) which may serve an important role …See details»
GeneSegues Secures $1M NCI Contract to Develop Cancer …
Nov 12, 2014 NEW YORK (GenomeWeb) – GeneSegues Therapeutics this week announced that it has received a $1 million contract from the National Cancer Institute to continue …See details»
GeneSegues’s Competitors, Revenue, Number of Employees
GeneSegues’s Profile, Revenue and Employees. GeneSegues develops and commercializes RNAi therapeutics for the treatment of cancer. GeneSegues’s primary competitors include …See details»
Genesegues Inc - Company Profile and News - Bloomberg Markets
Company profile page for Genesegues Inc including stock price, company news, executives, board members, and contact informationSee details»
Research programme: gene silencing therapeutics - GeneSegues
GeneSegues is developing a series of nucleic acid compounds compressed and encapsulated in targeted molecular-sized nanocapsules for the treatment of cancer.See details»
GeneSegues Therapeutics - Company Profile - Tracxn
GeneSegues Therapeutics - Developer of RNAi-based targeted drugs for the treatment of cancer. This company is not active anymore.See details»
SYNTIRON | HUMAN VACCINE RESEARCH
Antibiotics were the single most important medical advance of the 1900s, but almost immediately, resistant bacteria emerged and have continued to spread. In contrast, vaccines provide lasting …See details»
Delphia Therapeutics - Crunchbase
Delphia Therapeutics focuses on cancer treatment development, while Latigo Biotherapeutics, Meristem Therapeutics, GeneSegues Therapeutics, and Therapeutic Developments are …See details»
Laura Brod - Wikipedia
Due to her personal experience with cancer, Brod entered the world of Biotech as the CEO of Genesegues Therapeutics. Genesegues, Inc. had developed a precision targeted anti-cancer …See details»
Surtovol - Getting to the Nucleus of the Matter
Surtovol™ is a pioneer in ligand-directed nanocapsule delivery of gene therapy at the biologically-relevant sub-50 nanometer (“s50”) threshold. We prioritize partnering in next-generation gene …See details»
GeneSegues, Inc. Appoints New SAB Member - BioSpace
Dec 10, 2003 GeneSegues, Inc., a biopharmaceutical company that develops nanoencapsulated therapeutics, today announced the appointment of Dr. Erkki Ruoslahti, Ph.D., M.D., to its …See details»
Gretchen M. Unger | GeneSegues Therapeutics | United States of …
The founder of GeneSegues and inventor of the s50 technology, Dr. Unger is a leading expert in targeted nanoparticle sciences and lipid raft-mediated cell delivery, with additional expertise in …See details»
GeneSegues gets gov't contract to develop a topical vaccine for ...
Dec 19, 2014 Minneapolis vaccine developer GeneSegues Therapeutics has a new government contract to develop a DNA vaccine against Venezuelan equine encephalitis virus - an …See details»
RoverMed BioSciences - Crunchbase Company Profile & Funding
RoverMed’s nanocapsule technology has been proven, through years of intensive research and development, by Minnesota-based GeneSegues Therapeutics. A precision target drug delivery …See details»
NMDP BioTherapies | Advancing Your Cell or Gene Therapy
NMDP BioTherapies designs solutions that accelerate your autologous or allogeneic cell and gene therapy development.See details»
The developing role of gene therapy - Sciensus
Feb 4, 2025 Our expert Mathieu Loiseau shares his insights on the developing role of gene therapy in finding solutions to rare diseases.See details»